Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma

PHASE3CompletedINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

June 8, 2004

Primary Completion Date

May 3, 2013

Study Completion Date

December 19, 2017

Conditions
Lymphoma
Interventions
BIOLOGICAL

rituximab

comparing two maintenance schedules of Rituximab

Trial Locations (26)

1000

Clinical Center Skopje, Skopje

2002

Hôpital Pourtalès, Neuchâtel

2121

Sandton Oncology Centre, Johannesburg

3010

Inselspital Bern, Bern

3600

SpitalSTS AG Simmental-Thun-Saanenland, Thun

4226

Breitenbach Praxis Dr. Haberthür, Breitenbach

6500

Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli, Bellinzona

7500

Panorama Medical Centre, Cape Town

8063

City Hospital Triemli, Zurich

20141

Istituto Europeo di Oncologia IEO, Milan

83310

NOU - National Institute for Oncology, Bratislava

Unknown

Clinical Center - Institute of Hematology, São Paulo

SCG-11000

Clinical Center of Serbia, Belgrade

CH-5001

Kantonspital Aarau, Aarau

CH-5404

Kantonsspital Baden, Baden

CH-4016

St. Claraspital AG, Basel

CH-4031

Universitaetsspital Basel, Basel

CH-4101

Kantonsspital Bruderholz, Bruderholz

CH-7000

Kantonsspital Graubuenden, Chur

CH-1211

Hopital Cantonal Universitaire de Geneve, Geneva

CH-1011

Centre Hospitalier Universitaire Vaudois, Lausanne

CH-4410

Kantonsspital, Liestal

CH-6900

Istituto Oncologico della Svizzera Italiana, Lugano

CH-9007

Kantonsspital - St. Gallen, Sankt Gallen

CH-8032

Klinik Hirslanden, Zurich

CH-8091

UniversitaetsSpital Zuerich, Zurich

All Listed Sponsors
lead

Swiss Cancer Institute

OTHER

NCT00227695 - Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter